Additionally, MMP-1 is independently associated with cancer-specific survival (CSS) in patients with CRC, and MMP-1 expression in tumor-free mucosa can be used to help guide providers in the identification of patients with colorectal cancer who may require additional systemic chemotherapy or more intensive adjuvant treatments in addition to curative resection [93]. The gene discussed is MMP1; the disease is cancer.